Global Burning Mouth Syndrome Testing Market Size, Share, and COVID-19 Impact Analysis, By Test Type (Oral Swab Tests, Blood Tests, Allergy Tests, Salivary Tests, and Others), By End-User (Specialty Clinics, Diagnostic Laboratories, Hospitals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Burning Mouth Syndrome Testing Market Insights Forecasts to 2033

• The Global Burning Mouth Syndrome Testing Market Size was Estimated at USD 463.7 Million in 2023
• The Market Size is Expected to Grow at a CAGR of around 5.67% from 2023 to 2033
• The Worldwide Burning Mouth Syndrome Testing Market Size is Expected to Reach USD 805.3 Million by 2033
• Asia-Pacific is Expected to Grow the fastest during the forecast period.

The Global Burning Mouth Syndrome Testing Market Size is expected to cross USD 805.3 Million by 2033, growing at a CAGR of 5.67% from 2023 to 2033.

Market Overview

The global burning mouth syndrome testing market focuses on the diagnostic procedures, tools, and services used to identify burning mouth syndrome (BMS), a chronic or recurring condition characterized by a burning sensation in the mouth that has no obvious medical or dental cause. BMS is frequently associated with symptoms such as dry mouth, altered taste, and a scalding sensation, which typically affect the tongue, lips, and oral mucosa. The global burning mouth syndrome testing market presents significant opportunities as awareness and diagnosis of orofacial pain disorders rise. As healthcare systems worldwide shift toward more personalized and preventive care, the demand for targeted diagnostic solutions for chronic conditions such as BMS grows. Emerging diagnostic technologies, such as molecular biomarkers and salivary diagnostics, present promising opportunities for more accurate, non-invasive testing.

Report Coverage

This research report categorizes the burning mouth syndrome testing market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the burning mouth syndrome testing market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the burning mouth syndrome testing market.

Driving Factors

The global burning mouth syndrome testing market is being driven by an increasing prevalence of unexplained oral discomfort disorders and a greater emphasis on differential diagnosis in chronic pain management. The increased awareness among healthcare professionals of BMS and its multifactorial nature is resulting in more frequent referrals for testing. Improvements in diagnostic technologies, such as high-sensitivity blood assays, salivary diagnostics, and neurological screenings, allow for earlier and more accurate detection of BMS-related conditions. Furthermore, the rising prevalence of associated conditions such as diabetes, thyroid disorders, and psychological stress promotes market expansion. Supportive insurance policies and rising healthcare spending, particularly in developed regions, are also driving market growth.

Restraining Factors

The global burning mouth syndrome testing market faces challenges such as low awareness and underdiagnosis of BMS, particularly in emerging economies. The lack of standardized testing protocols and definitive diagnostic markers reduces clinical clarity and delays diagnosis. High diagnostic costs and limited reimbursement coverage may be barriers to widespread adoption. Furthermore, overlapping symptoms with other oral conditions can lead to misdiagnosis or delayed treatment.

Market Segmentation

The burning mouth syndrome testing market share is classified into test type and end-user.   

• The oral swab tests segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the test type, the burning mouth syndrome testing market is divided into oral swab tests, blood tests, allergy tests, salivary tests, and others. Among these, the oral swab tests segment held the greatest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. This is primarily because oral swab tests are non-invasive, easy to administer, and have rapid diagnostic capabilities. These tests are increasingly being used to identify infections, inflammatory markers, and other oral health issues that may be associated with burning mouth syndrome.

• The hospitals segment accounted for the majority of the share in 2023 and is estimated to grow at a remarkable CAGR during the projected timeframe.

Based on the end-user, the burning mouth syndrome testing market is divided into specialty clinics, diagnostic laboratories, hospitals, and others. Among these, the hospitals segment accounted for the majority of the share in 2023 and is estimated to grow at a remarkable CAGR during the projected timeframe. This is due to the presence of advanced diagnostic infrastructure, multidisciplinary expertise, and comprehensive patient care in hospitals. Hospitals are frequently the first point of contact for patients with complex or persistent symptoms, making them an important resource for diagnosing burning mouth syndrome.

Regional Segment Analysis of the Burning Mouth Syndrome Testing Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the burning mouth syndrome testing market over the predicted timeframe.

North America is anticipated to hold the largest share of the burning mouth syndrome testing market over the predicted timeframe. This is due to its advanced healthcare infrastructure, high diagnostic awareness, and extensive network of specialized clinics and diagnostic laboratories. The region also has a higher prevalence of conditions linked to burning mouth syndrome, such as diabetes, hormonal changes, and psychological disorders, which necessitates early diagnostic testing. Furthermore, government and private insurance support for diagnostic services, combined with widespread use of innovative testing technologies, allows for timely and accurate diagnosis. The presence of major diagnostic companies, as well as ongoing research initiatives, strengthens North America's position as a market leader in burning mouth syndrome testing.

Asia-Pacific is expected to grow at the fastest CAGR growth of the burning mouth syndrome testing market during the forecast period. The growth is being driven by increased healthcare access, rising oral health awareness, and a growing geriatric population in countries such as China, India, and Japan. The region is seeing an increase in chronic diseases and nutritional deficiencies, both of which are common causes of burning mouth syndrome, necessitating improved diagnostic solutions. Governments throughout the region are investing heavily in healthcare infrastructure and promoting early disease detection, particularly in rural and underserved areas. Furthermore, the growing use of private diagnostic laboratories and telehealth platforms is making testing more accessible, accelerating demand for burning mouth syndrome diagnostics in Asia-Pacific countries.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the burning mouth syndrome testing market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers and  acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• bioMérieux SA
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Merck KGaA
• QIAGEN N.V.
• Siemens Healthineers AG
• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the Burning Mouth Syndrome Testing market based on the below-mentioned segments: 

Global Burning Mouth Syndrome Testing Market, By Test Type

• Oral Swab Tests
• Blood Tests
• Allergy Tests
• Salivary Tests
• Others

Global Burning Mouth Syndrome Testing Market, By End-User

• Specialty Clinics
• Diagnostic Laboratories
• Hospitals
• Others

Global Burning Mouth Syndrome Testing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa